Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ANGO AngioDynamics	$11.54 -1.5%	$10.46	$6.29 ▼ $13.50	$482.86M	0.78	630,105 shs	430,153 shs
ATEC Alphatec	$14.89 +4.4%	$15.16	$5.08 ▼ $16.70	$2.11B	1.05	1.85 million shs	2.41 million shs
OSUR OraSure Technologies	$3.02 -1.3%	$3.14	$2.36 ▼ $4.60	$223.80M	0.46	501,301 shs	510,300 shs
SIBN SiBone	$14.74 -2.4%	$15.38	$11.70 ▼ $20.05	$651.43M	0.83	483,056 shs	391,491 shs
SRDX Surmodics	$27.99 0.0%	$32.46	$26.00 ▼ $40.38	$400.33M	1.31	125,649 shs	75,450 shs

Analysts Agree—These Gold Picks Outshine the Rest

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ANGO AngioDynamics	-1.54%	+4.91%	+6.56%	+32.80%	+85.53%
ATEC Alphatec	+4.42%	+13.32%	+1.29%	+41.94%	+158.96%
OSUR OraSure Technologies	-1.31%	+2.37%	-8.21%	-5.63%	-25.80%
SIBN SiBone	-2.38%	-0.27%	+0.20%	-11.31%	+11.50%
SRDX Surmodics	-0.04%	-2.24%	-12.28%	-7.35%	-27.36%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ANGO AngioDynamics	$11.54 -1.5%	$10.46	$6.29 ▼ $13.50	$482.86M	0.78	630,105 shs	430,153 shs
ATEC Alphatec	$14.89 +4.4%	$15.16	$5.08 ▼ $16.70	$2.11B	1.05	1.85 million shs	2.41 million shs
OSUR OraSure Technologies	$3.02 -1.3%	$3.14	$2.36 ▼ $4.60	$223.80M	0.46	501,301 shs	510,300 shs
SIBN SiBone	$14.74 -2.4%	$15.38	$11.70 ▼ $20.05	$651.43M	0.83	483,056 shs	391,491 shs
SRDX Surmodics	$27.99 0.0%	$32.46	$26.00 ▼ $40.38	$400.33M	1.31	125,649 shs	75,450 shs

Analysts Agree—These Gold Picks Outshine the Rest

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ANGO AngioDynamics	-1.54%	+4.91%	+6.56%	+32.80%	+85.53%
ATEC Alphatec	+4.42%	+13.32%	+1.29%	+41.94%	+158.96%
OSUR OraSure Technologies	-1.31%	+2.37%	-8.21%	-5.63%	-25.80%
SIBN SiBone	-2.38%	-0.27%	+0.20%	-11.31%	+11.50%
SRDX Surmodics	-0.04%	-2.24%	-12.28%	-7.35%	-27.36%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ANGO AngioDynamics	2.50	Moderate Buy	$19.33	67.53% Upside
ATEC Alphatec	2.75	Moderate Buy	$18.14	21.85% Upside
OSUR OraSure Technologies	1.50	Reduce	$3.00	-0.66% Downside
SIBN SiBone	2.50	Moderate Buy	$23.00	56.04% Upside
SRDX Surmodics	2.00	Hold	$43.00	53.63% Upside

Current Analyst Ratings Breakdown

Latest ANGO, SIBN, SRDX, ATEC, and OSUR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/16/2025	ATEC Alphatec	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$14.00 ➝ $16.00
10/15/2025	SIBN SiBone	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$22.00 ➝ $20.00
10/14/2025	ATEC Alphatec	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
10/8/2025	ANGO AngioDynamics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
10/8/2025	OSUR OraSure Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
10/8/2025	SIBN SiBone	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
10/8/2025	SRDX Surmodics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
10/3/2025	ANGO AngioDynamics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$17.00 ➝ $18.00
9/27/2025	ANGO AngioDynamics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/27/2025	ATEC Alphatec	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/27/2025	OSUR OraSure Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)

(Data available from 10/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ANGO AngioDynamics	$300.72M	1.58	$0.48 per share	24.06	$4.34 per share	2.66
ATEC Alphatec	$682.24M	3.23	N/A	N/A	($0.10) per share	-148.90
OSUR OraSure Technologies	$185.83M	1.19	$0.04 per share	78.82	$5.50 per share	0.55
SIBN SiBone	$167.18M	3.80	N/A	N/A	$3.98 per share	3.70
SRDX Surmodics	$126.08M	3.17	$0.31 per share	90.50	$8.33 per share	3.36

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ANGO AngioDynamics	-$33.99M	-$0.78	N/A	N/A	N/A	-10.67%	-3.16%	-2.07%	N/A
ATEC Alphatec	-$162.12M	-$1.13	N/A	N/A	N/A	-24.33%	N/A	-21.44%	10/30/2025 (Confirmed)
OSUR OraSure Technologies	-$19.50M	-$0.67	N/A	N/A	N/A	-36.84%	-10.81%	-9.44%	11/5/2025 (Estimated)
SIBN SiBone	-$30.91M	-$0.56	N/A	N/A	N/A	-12.83%	-14.20%	-10.38%	11/11/2025 (Estimated)
SRDX Surmodics	-$11.54M	-$1.23	N/A	34.99	N/A	-14.59%	-2.99%	-1.99%	11/5/2025 (Estimated)

Latest ANGO, SIBN, SRDX, ATEC, and OSUR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/11/2025	Q3 2025	SIBN SiBone	-$0.17	N/A	N/A	N/A	$46.67 million	N/A
11/5/2025	Q3 2025	OSUR OraSure Technologies	-$0.16	N/A	N/A	N/A	$28.96 million	N/A
11/5/2025	Q4 2025	SRDX Surmodics	-$0.19	N/A	N/A	N/A	$30.14 million	N/A
10/30/2025	Q3 2025	ATEC Alphatec	-$0.06	N/A	N/A	N/A	$182.78 million	N/A
10/2/2025	Q1 2026	ANGO AngioDynamics	-$0.12	-$0.10	+$0.02	-$0.26	$72.69 million	$75.71 million
8/8/2025	Q3 2025	SRDX Surmodics	-$0.21	$0.06	+$0.27	-$0.37	$28.04 million	$29.57 million
8/4/2025	Q2 2025	SIBN SiBone	-$0.19	-$0.14	+$0.05	-$0.14	$48.12 million	$48.63 million
7/31/2025	Q2 2025	ATEC Alphatec	-$0.06	$0.02	+$0.08	-$0.27	$178.85 million	$185.54 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ANGO AngioDynamics	N/A	N/A	N/A	N/A	N/A
ATEC Alphatec	N/A	N/A	N/A	N/A	N/A
OSUR OraSure Technologies	N/A	N/A	N/A	N/A	N/A
SIBN SiBone	N/A	N/A	N/A	N/A	N/A
SRDX Surmodics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ANGO AngioDynamics	N/A	2.29	1.38
ATEC Alphatec	23.22	2.88	1.77
OSUR OraSure Technologies	N/A	7.12	6.33
SIBN SiBone	0.21	8.38	7.00
SRDX Surmodics	0.27	3.91	3.10

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ANGO AngioDynamics	89.43%
ATEC Alphatec	66.35%
OSUR OraSure Technologies	93.50%
SIBN SiBone	98.11%
SRDX Surmodics	96.63%

Insider Ownership

Company	Insider Ownership
ANGO AngioDynamics	6.00%
ATEC Alphatec	20.90%
OSUR OraSure Technologies	3.90%
SIBN SiBone	4.00%
SRDX Surmodics	8.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ANGO AngioDynamics	760	41.20 million	38.73 million	Optionable
ATEC Alphatec	700	147.98 million	117.06 million	Optionable
OSUR OraSure Technologies	840	73.14 million	70.29 million	Optionable
SIBN SiBone	350	43.14 million	41.42 million	Optionable
SRDX Surmodics	450	14.30 million	13.03 million	Optionable

ANGO, SIBN, SRDX, ATEC, and OSUR Headlines

Recent News About These Companies

Credit Industriel ET Commercial Decreases Stake in Surmodics, Inc. $SRDX

October 14, 2025 | marketbeat.com

Surmodics (NASDAQ:SRDX) Receives "Sell (D-)" Rating from Weiss Ratings

October 9, 2025 | marketbeat.com

Surmodics, Inc. (NASDAQ:SRDX) Receives Consensus Recommendation of "Hold" from Analysts

October 3, 2025 | marketbeat.com

Surmodics (NASDAQ:SRDX) Share Price Passes Above 200 Day Moving Average - Here's What Happened

September 25, 2025 | marketbeat.com

GTCR purchase of Surmodics would hurt medical device market, FTC says

August 22, 2025 | msn.com

SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts

August 12, 2025 | zacks.com

SurModics: Hold Rating Amid Mixed Financial Performance and Legal Uncertainties

August 11, 2025 | tipranks.com

SurModics: Balancing Strong Financial Performance with Acquisition Uncertainty

August 8, 2025 | tipranks.com

SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

August 8, 2025 | zacks.com

What's Next: Surmodics's Earnings Preview

August 8, 2025 | benzinga.com

SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates

August 8, 2025 | zacks.com

Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance

August 8, 2025 | businesswire.com

Surmodics (SRDX) Q3 EPS Turns Positive

August 8, 2025 | fool.com

Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8

August 6, 2025 | businesswire.com

Surmodics falls as parties, FTC ask for extension of briefing schedule

July 31, 2025 | msn.com

Surmodics jumps amid pre-trial hearing in FTC's suit to block sale to GTCR

July 25, 2025 | msn.com

Surmodics, Inc. (SRDX) stock price, news, quote & history - Yahoo Finance

July 3, 2025 | au.finance.yahoo.com

QuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound?

June 6, 2025 | msn.com

Why Is SurModics (SRDX) Up 6% Since Last Earnings Report?

May 30, 2025 | zacks.com

Surmodics, Ballinasloe, offers production operator opportunities

May 15, 2025 | advertiser.ieA

Are Options Traders Betting on a Big Move in Surmodics Stock?

May 2, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANGO, SIBN, SRDX, ATEC, and OSUR Company Descriptions

AngioDynamics NASDAQ:ANGO

$11.54 -0.18 (-1.54%)

Closing price 10/17/2025 04:00 PM Eastern

Extended Trading

$11.53 -0.01 (-0.09%)

As of 10/17/2025 04:31 PM Eastern

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

Alphatec NASDAQ:ATEC

$14.89 +0.63 (+4.42%)

Closing price 10/17/2025 04:00 PM Eastern

Extended Trading

$14.81 -0.08 (-0.54%)

As of 10/17/2025 07:46 PM Eastern

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

OraSure Technologies NASDAQ:OSUR

$3.02 -0.04 (-1.31%)

Closing price 10/17/2025 04:00 PM Eastern

Extended Trading

$3.02 +0.00 (+0.17%)

As of 10/17/2025 05:48 PM Eastern

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.

SiBone NASDAQ:SIBN

$14.74 -0.36 (-2.38%)

Closing price 10/17/2025 04:00 PM Eastern

Extended Trading

$14.74 0.00 (0.00%)

As of 10/17/2025 04:31 PM Eastern

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Surmodics NASDAQ:SRDX

$27.99 -0.01 (-0.04%)

Closing price 10/17/2025 04:00 PM Eastern

Extended Trading

$28.02 +0.03 (+0.11%)

As of 10/17/2025 04:31 PM Eastern

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ANGO, SIBN, SRDX, ATEC, and OSUR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ANGO, SIBN, SRDX, ATEC, and OSUR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ANGO, SIBN, SRDX, ATEC, and OSUR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANGO, SIBN, SRDX, ATEC, and OSUR Company Descriptions

AngioDynamics NASDAQ:ANGO

Alphatec NASDAQ:ATEC

OraSure Technologies NASDAQ:OSUR

SiBone NASDAQ:SIBN

Surmodics NASDAQ:SRDX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ANGO, SIBN, SRDX, ATEC, and OSUR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ANGO, SIBN, SRDX, ATEC, and OSUR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ANGO, SIBN, SRDX, ATEC, and OSUR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANGO, SIBN, SRDX, ATEC, and OSUR Company Descriptions

AngioDynamics NASDAQ:ANGO

Alphatec NASDAQ:ATEC

OraSure Technologies NASDAQ:OSUR

SiBone NASDAQ:SIBN

Surmodics NASDAQ:SRDX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools